Furthermore, these ceanothanes not only bind to the AChE catalytic site but also to the PAS and in this way could inhibit the formation of senile plaques typical of Alzheimer’s disease. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.